Advertisement
CI vs ELV
Which Stock Would AI Choose? Cigna (CI) vs. Elevance Health (ELV) Stock Comparison
Key Takeaways
- Cigna (CI) and Elevance Health (ELV) are major players in the U.S. health insurance sector, offering investors exposure to managed care, pharmacy benefits, and related services.
- In recent market activity, ELV has delivered stronger year-to-date returns of approximately 21% compared to CI’s roughly 7%, reflecting differences in momentum and investor positioning.
- Both companies face sector-wide pressures from medical cost trends and regulatory developments, with upcoming quarterly earnings releases serving as near-term catalysts.
- CI trades at a lower absolute price level with analyst price targets suggesting notable upside potential, while ELV has demonstrated more consistent outperformance relative to broader benchmarks in recent periods.
- Market sentiment remains constructive for both, supported by stable fundamentals, though ELV has shown greater resilience in price behavior over the past several weeks.
- Relative performance highlights trade-offs in growth consistency versus valuation appeal, relevant for investors seeking healthcare sector diversification.
Introduction
Cigna (CI) and Elevance Health (ELV) represent two leading health services organizations whose stocks often attract attention from investors focused on the managed care industry. This comparison examines their recent stock behavior, business profiles, and relative positioning within a sector influenced by healthcare utilization trends and policy shifts. Portfolio managers and active traders evaluating large-cap healthcare holdings may find this analysis useful for assessing diversification opportunities and momentum differentials in the current environment.
CI Overview and Recent Performance
The Cigna Group (CI) provides health insurance, pharmacy benefit management through its Evernorth segment, and related services to employers, government programs, and individuals. In recent market activity, CI shares have traded in a range around $280–$300, closing most recently near 291.80 with modest daily gains. Year-to-date performance stands at approximately 6.6%, lagging the broader market, while the one-year return hovers near 4%. Sentiment has been shaped by upcoming second-quarter 2026 earnings scheduled for July 30, alongside analyst upgrades and ongoing sector dynamics such as medical cost management. Broader timeframe references show resilience despite a pullback from prior highs, supported by reaffirmed guidance and operational stability.
ELV Overview and Recent Performance
Elevance Health (ELV) operates as a diversified health benefits company offering insurance plans, wellness programs, and integrated care services primarily in the United States. Shares have shown stronger recent momentum, closing most recently at 420.39 after reaching new 52-week highs near 427. Year-to-date returns approximate 21%, notably outperforming benchmarks, with the one-year return also positive and ahead of CI. Recent market activity reflects investor focus on second-quarter 2026 results due July 15 and raised full-year guidance elements from prior periods. Sentiment benefits from consistent capital return programs and positioning within a resilient healthcare segment amid broader economic conditions.
Trending AI Robots
Tickeron maintains a curated selection of AI-powered trading bots on its Trending AI Robots page. The platform features hundreds of AI trading bots that analyze and trade thousands of different tickers across varied market conditions. Only those demonstrating the strongest alignment with prevailing trends, risk-adjusted performance metrics, and statistical robustness earn placement in this trending section. Available bots exhibit a wide range of annualized returns, win rates, Sharpe ratios, and strategy styles, including day trading, swing approaches, and multi-asset models, with documented examples reaching up to 54% annualized returns or 85% win rates in specific sectors during forward-tested periods. All AI trading bots differ in trading styles, timeframes, performance statistics, and ticker focus. Traders interested in exploring these automated strategies can review detailed performance data directly on the platform.
Head-to-Head Comparison
Cigna (CI) and Elevance Health (ELV) share core exposure to the health insurance and services sector yet differ in scale, growth emphasis, and recent price trajectories. ELV has recorded superior year-to-date and recent period returns, indicating stronger momentum, while CI offers a comparatively lower share price and potentially wider analyst target upside relative to current levels. Both companies navigate similar risk factors, including medical loss ratio pressures and reimbursement changes, though ELV’s larger market capitalization and diversified operations may provide additional stability. Sector sentiment favors healthcare defensiveness, with ELV appearing to benefit more from recent positioning shifts. Trade-offs include CI’s valuation appeal against ELV’s demonstrated outperformance consistency in prevailing conditions.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative momentum, and positioning within recent market activity, Tickeron’s AI would currently assign a probabilistic preference toward Elevance Health (ELV). Stronger year-to-date performance and proximity to recent highs suggest more favorable alignment with prevailing conditions compared to CI’s more muted returns, though both remain subject to earnings outcomes and sector variables that could alter relative standings.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and LimitationsTo compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CI is a Buy and ELV is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CI’s FA Score shows that 1 FA rating(s) are green whileELV’s FA Score has 3 green FA rating(s).
- CI’s FA Score: 1 green, 4 red.
- ELV’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CI’s TA Score shows that 6 TA indicator(s) are bullish while ELV’s TA Score has 4 bullish TA indicator(s).
- CI’s TA Score: 6 bullish, 5 bearish.
- ELV’s TA Score: 4 bullish, 4 bearish.
Price Growth
CI (@Managed Health Care) experienced а +7.99% price change this week, while ELV (@Managed Health Care) price change was +4.16% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.83%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was +35.30%.
Reported Earning Dates
CI is expected to report earnings on Jul 30, 2026.
ELV is expected to report earnings on Jul 15, 2026.
Industries' Descriptions
@Managed Health Care (+0.83% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CI | ELV | CI / ELV | |
| Capitalization | 80.6B | 92.3B | 87% |
| EBITDA | 12.1B | N/A | - |
| Gain YTD | 11.889 | 22.531 | 53% |
| P/E Ratio | 12.91 | 18.02 | 72% |
| Revenue | 268B | 200B | 134% |
| Total Cash | 7.8B | N/A | - |
| Total Debt | 30.9B | 31.8B | 97% |
CI | ELV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 58 | 82 | |
SMR RATING 1..100 | 56 | 98 | |
PRICE GROWTH RATING 1..100 | 51 | 18 | |
P/E GROWTH RATING 1..100 | 76 | 24 | |
SEASONALITY SCORE 1..100 | 47 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CI's Valuation (5) in the Managed Health Care industry is in the same range as ELV (7). This means that CI’s stock grew similarly to ELV’s over the last 12 months.
CI's Profit vs Risk Rating (58) in the Managed Health Care industry is in the same range as ELV (82). This means that CI’s stock grew similarly to ELV’s over the last 12 months.
CI's SMR Rating (56) in the Managed Health Care industry is somewhat better than the same rating for ELV (98). This means that CI’s stock grew somewhat faster than ELV’s over the last 12 months.
ELV's Price Growth Rating (18) in the Managed Health Care industry is somewhat better than the same rating for CI (51). This means that ELV’s stock grew somewhat faster than CI’s over the last 12 months.
ELV's P/E Growth Rating (24) in the Managed Health Care industry is somewhat better than the same rating for CI (76). This means that ELV’s stock grew somewhat faster than CI’s over the last 12 months.
| CI | ELV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 70% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 52% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 50% | 1 day ago 66% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 58% |
| TrendMonth ODDS (%) | 1 day ago 62% | 1 day ago 53% |
| Advances ODDS (%) | 1 day ago 63% | 12 days ago 56% |
| Declines ODDS (%) | 14 days ago 55% | 14 days ago 56% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 67% |
| Aroon ODDS (%) | 1 day ago 77% | 1 day ago 59% |
Advertisement
CI and
Correlation & Price change
A.I.dvisor indicates that over the last year, CI has been loosely correlated with CVS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CI jumps, then CVS could also see price increases.